| 000 | 05582nam a22006255i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-49744-5 | ||
| 003 | DE-He213 | ||
| 005 | 20251030111438.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240222s2024 sz | s |||| 0|eng d | ||
| 020 |
_a9783031497445 _9978-3-031-49744-5 |
||
| 024 | 7 |
_a10.1007/978-3-031-49744-5 _2doi |
|
| 050 | 4 | _aQP361-430 | |
| 050 | 4 | _aQP90.2 | |
| 072 | 7 |
_aPSAN _2bicssc |
|
| 072 | 7 |
_aSCI089000 _2bisacsh |
|
| 072 | 7 |
_aPSAN _2thema |
|
| 245 | 1 | 0 |
_aRegenerative Medicine and Brain Repair _h[electronic resource] / _cedited by Philip V. Peplow, Bridget Martinez, Thomas A. Gennarelli. |
| 250 | _a1st ed. 2024. | ||
| 264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2024. |
|
| 300 |
_aXIV, 343 p. 29 illus., 28 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aStem Cell Biology and Regenerative Medicine, _x2196-8993 ; _v75 |
|
| 505 | 0 | _aInitiating and Facilitating Brain Repair: Factors, Principles, and Mechanisms -- Strategies to Upgrade the Stem Cell Application for Brain Transplantation -- Neural Stem Cell Intervention in Traumatic Brain Injury -- Neurotrophic Factors in Parkinson’s Disease: Clinical Trials -- Emerging Nanotechnology for the Treatment and Diagnosis of Parkinson’s Disease (PD) and Alzheimer’s Disease (AD) -- Poly(Butyl Cyanoacrylate) Nanoparticles deliver β-Nerve Growth Factor to the Brain after Traumatic Brain Injury -- The Significance of Biomaterials in Stem Cell-Based Regenerative Medicine -- Endogenous in situ Tissue Regeneration using Inductive Bioscaffolds after Acute Brain Injury -- Alginate Nanofibre Scaffolds for Amyotrophic Lateral Sclerosis -- Developing High-Fidelity in vitro Models of Traumatic Brain Injury to Test Therapeutic Biomaterials -- Challenges and Future Perspectives of Using Bioactive Scaffolds in Brain Repair. | |
| 520 | _aThis book presents the latest knowledge, trends, and advances in cell transplantation and innovations in developing microspheres, 3D biomaterial constructs to enhance transfer, and cell survival to specific regions of the brain. Neurodegenerative diseases and brain injury are increasing. Medications currently only temporarily reduce some of the symptoms but do not cure or delay progression of the disease. Development of effective treatments dramatically improves the independent living and quality of life of patients. Cell transplantation strategies offer an approach to facilitating brain repair, but efficacy is often limited by low in vivo survival rates of cells that are injected in suspension. Transplanting cells that are attached to or encapsulated within a biomaterial construct has the advantage of maintaining cell-cell and cell-material interactions and improving cell survival in vivo. Biomaterials that have been used in preclinical studies to assist with in vivo cell transfer and survival include heparin-chitosan microspheres, poly(lactic-co-glycolic acid) microspheres, RADA 16 microspheres, poly(desaminotyrosyl tyrosine ethyl ester carbonate) microscale scaffolds, carbon nanotubes, collagen-chitosan scaffolds, poly(L-lactic acid) scaffolds, agarose hydrogels, gelatin methacrylate hydrogels, and agarose micro-columns with an extracellular matrix interior. Incorporating growth factors (e.g., glial-derived neurotrophic factor, neurotrophin 3) into the biomaterial constructs increased cell survival and incorporation into the host tissue. International experts in the fields of both experimental and clinical neurological research contribute chapters to this book and discuss the latest achievements in cell transplantation and matrix-assisted cell transfer/survival technologies for diseases such as Alzheimer’s disease, Parkinson’s disease, and brain injuries such as stroke and traumatic brain injury. It is envisaged that research findings in experimental animal models of Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and stroke promote clinical trials using biomaterial-assisted transfer of cells. | ||
| 650 | 0 |
_aNervous system _xRegeneration. _971547 |
|
| 650 | 0 |
_aRegenerative medicine. _967458 |
|
| 650 | 0 |
_aStem cells. _967435 |
|
| 650 | 0 | _aBiomedical engineering. | |
| 650 | 0 | _aBiomaterials. | |
| 650 | 1 | 4 |
_aRegeneration and Repair in the Nervous System. _971548 |
| 650 | 2 | 4 |
_aRegenerative Medicine and Tissue Engineering. _967459 |
| 650 | 2 | 4 |
_aStem Cell Biology. _967439 |
| 650 | 2 | 4 | _aBiomedical Engineering and Bioengineering. |
| 650 | 2 | 4 | _aBiomaterials. |
| 700 | 1 |
_aPeplow, Philip V. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _971549 |
|
| 700 | 1 |
_aMartinez, Bridget. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _971550 |
|
| 700 | 1 |
_aGennarelli, Thomas A. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _971551 |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031497438 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031497452 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031497469 |
| 830 | 0 |
_aStem Cell Biology and Regenerative Medicine, _x2196-8993 ; _v75 _971552 |
|
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-3-031-49744-5 |
| 912 | _aZDB-2-SBL | ||
| 912 | _aZDB-2-SXB | ||
| 999 |
_c57803 _d57803 |
||